| Cytokine targets | Typical physiologic functions | Potential application | Sample source |
| IL-4 | Activating Th2 immunity; priming the vessel wall for eosinophil extravasations | Diagnosis, therapeutic | Tissue, sputum, BALF, serum | IL-5 | Promoting eosinophilia | Diagnosis, therapeutic | Tissue, sputum, BALF, serum | IL-13 | Mounting BHR, goblet cell metaplasia | Diagnosis, therapeutic | Tissue, sputum, BALF, serum | IL-25 | Activating innate lymphoid cells | Diagnosis, therapeutic | Tissue, sputum, BALF, serum | IL-33 | Activating innate lymphoid cells | Diagnosis, therapeutic | Tissue, sputum, BALF, serum | TSLP | Activating dendritic cells and promoting Th2 immunity | Diagnosis, therapeutic | Tissue, serum | Eotaxin-1/CCL11 | Eosinophil chemotaxis | Diagnosis, prediction | Tissue, sputum, BALF | Eotaxin-2/CCL24 | Eosinophil chemotaxis | Diagnosis | Tissue, sputum, BALF | Eotaxin-3/CCL26 | Eosinophil chemotaxis | Diagnosis | Blood, tissue | MCP-4/CCL13 | Chemoattractant for eosinophils, monocytes, lymphocytes, and basophils | Diagnosis, prediction | Sputum, BALF, plasma | IL-9 | Promoting IL-4-driven antibody, inducing goblet cell metaplasia | Diagnosis, therapeutic | Tissue, serum | CCL17 | Recruitment of Th2 cells | Diagnosis, prediction | Sputum, serum |
|
|